HUTCHMED (China) HCM
NASDAQ HCM
$12.59 +0.00 (+0.00%)
As of: Aug 20, 2026 · 3:56 PM EDT

HUTCHMED (China) (HCM) EBITDA Margin Growth (3y) (2018 - 2021)

HUTCHMED (China) (HCM) EBITDA Margin Growth (3y) (2018 - 2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (3y) (Qtr)
1 Haleon 43.85 Bn 42.88 Bn - -
2 Teva Pharmaceutical Industries 43.02 Bn 39.37 Bn 2.15 Bn 1,129.00
3 Zoetis 31.47 Bn 29.79 Bn 1.05 Bn 2.00
4 Takeda Pharmaceutical 28.59 Bn 22.79 Bn 5.10 Bn 59.00
5 United Therapeutics 22.20 Bn 19.53 Bn 683.80 Mn -1,031.00
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn -925.00
7 Neurocrine Biosciences 15.45 Bn 15.06 Bn 935.80 Mn -46.00
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn 6,666.00
9 Dr Reddys Laboratories 10.10 Bn 9.94 Bn - -
10 HUTCHMED (China) 2.18 Bn 2.18 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2021 26,056.00
Mar 31, 2021 32,653.00
Jun 30, 2019 -28,753.00
Jun 30, 2018 9,863.00